Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Parkinson Disease ll: Pathophysiology

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...

Neural Regulation

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.

Parkinson Disease l: Introduction

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...

Alterations in Muscle Tone lll

Alterations in Muscle Tone lll

Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

European S2k guidelines on management of autoimmune blistering diseases in children and adolescents.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026

Same author

Determination of levofloxacin, norfloxacin, and moxifloxacin in pharmaceutical dosage form or individually using derivative UV spectrophotometry.

BMC chemistry·2024

Same author

Body-site effect on CPM efficiency in healthy subjects: Central vs. peripheral stimulation.

Heliyon·2024

Same author

Reactogenicity, pregnancy outcomes, and SARS-CoV-2 infection following COVID-19 vaccination during pregnancy in Canada: A national prospective cohort study.

Vaccine·2023

Same author

A retrospective study on the liver toxicity of oral retinoids in Chanarin-Dorfman syndrome.

Journal of the European Academy of Dermatology and Venereology : JEADV·2023

Same author

Whole-body three-dimensional short tau inversion recovery and T1-weighted in/opposed phase MRI in the detection of neuroblastoma bone marrow metastasis: comparative study with PET/CT utilising bone marrow biopsy as the reference standard.

Clinical radiology·2023

Search research articles

Related Experiment Video

Updated: May 11, 2026

MALDI Imaging Mass Spectrometry of Neuropeptides in Parkinson's Disease

MALDI Imaging Mass Spectrometry of Neuropeptides in Parkinson's Disease

Published on: February 14, 2012

Asymmetric pain processing in Parkinson's disease.

Y Granovsky¹, I Schlesinger, S Fadel

¹Department of Neurology, Rambam Health Care Campus, Haifa, Israel; Laboratory of Clinical Neurophysiology, Faculty of Medicine, Technion, Haifa, Israel.

European Journal of Neurology

|May 25, 2013

Summary

Dopamine medication unexpectedly increased pain sensitivity in Parkinson's disease (PD) patients, particularly those with left-sided symptoms. This suggests altered pain processing in PD, highlighting the need for further research into pain management strategies.

Keywords:

Parkinson's disease conditioned pain modulation mesolimbic system pain

More Related Videos

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Published on: July 16, 2014

Related Experiment Videos

Last Updated: May 11, 2026

MALDI Imaging Mass Spectrometry of Neuropeptides in Parkinson's Disease

MALDI Imaging Mass Spectrometry of Neuropeptides in Parkinson's Disease

Published on: February 14, 2012

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Published on: July 16, 2014

Area of Science:

Neuroscience
Pain Research
Parkinson's Disease Research

Background:

Parkinson's disease (PD) is often associated with pain, potentially due to reduced endogenous pain inhibition.
The study investigates the endogenous pain inhibitory system in PD patients.

Purpose of the Study:

To assess the endogenous pain inhibitory system in Parkinson's disease patients.
To utilize the conditioned pain modulation (CPM) paradigm for this assessment.

Main Methods:

Twenty-six PD patients and 19 controls underwent psychophysical pain assessments.
Pain assessments were conducted before and after the administration of morning dopaminergic medication for PD patients.

Main Results:

Dopaminergic medication led to an unexpected increase in pain perception in PD patients.
This hyperalgesic effect was predominantly observed in patients with left-sided PD.
Conditioned pain modulation efficiency correlated inversely with age at onset and disease severity.

Conclusions:

Dopaminergic medication can induce hyperalgesia in PD patients, especially those with left-sided disease.
Sensory processing and pain modulation are significantly affected by dopaminergic therapy in PD.